-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATL-001 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATL-001 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATL-001 in Non-Small Cell Lung Cancer Drug Details: ATL-001 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATL-001 in Metastatic Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATL-001 in Metastatic Melanoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATL-001 in Metastatic Melanoma Drug Details: ATL-001 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATL-001 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATL-001 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ATL-001 in Non-Small Cell Lung Cancer Drug Details:ATL-001 is under development...
-
Product Insights
Net Present Value Model: ATL-001
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model ATL-001 Drug Details ATL-001 is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ATL-001
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ATL-001 Drug Details ATL-001 is under development for the treatment of advanced non-small cell...